ABOUT US

We are a forward-thinking, mid-size early phase contract research organization, in Canada and the U.S., offering biopharmaceutical companies of all sizes a proven, flexible approach to early drug development, including preclinical safety testing, clinical pharmacology (Phase I to Phase II), bioanalysis (preclinical to Phase IV), research services, and manufacturing and analytical services. Focused on your success … always available and always looking ahead. Moving in unison to deliver big impact with a personal touch.

More About Us

...working with Altasciences has been excellent, from both a bioanalytical, and a bioavailability study perspective. We are really impressed with their planning and execution abilities – I would not consider another provider for future work.

James M Mackay, President and Chief Executive Officer, Aristea Therapeutics

RESOURCE CENTER

FDA GUIDANCE ON COVID-19 VACCINES (BLOG/PODCAST)

Read the blog

FDA Guidance on COVID-19 Vaccines (blog/podcast)

The U.S. FDA issued Development and Licensure of Vaccines to Prevent COVID-19: Guidance for Industry to provide its perspective on (and recommendations) for the CMC (chemistry, manufacturing, and control), nonclinical, and clinical aspects related to such vaccines.

View All News & Events Go to Resource Center

SELECT A CATEGORY BELOW:

The Altascientist Scientific journal
E-Bulletins Highlights on key topics
Newsletters Latest industry and corporate news
Scientific Publications Posters, case studies and abstracts
Blog
Videos

Careers

Join our team! Work at Altasciences - View all clinical job postings

Bring your talents and forward-thinking approach to Altasciences and help us develop medicines for those who need them, faster. We have a number of opportunities for you to explore.

Learn More

NEWS & EVENTS

WEBINAR - Navigating Early Phase CNS-Active Drug Development with Dr. Beatrice Setnik, CSO

Webinar

WEBINAR - Navigating Early Phase CNS-Active Drug Development with Dr. Beatrice Setnik, CSO

Sep 22, 2020

As you work towards a successful New Drug Application (NDA) submission, there are many considerations that must be taken into account, specifically for CNS-active drugs.

View All News & Events Go to Resource Center

SELECT A CATEGORY BELOW:

Altasciences Events
Press Releases
Altasciences in the News
Press Kit
Webinars / Podcasts

Our Solutions

Dedicated Full-Time Experts Working for You!

At Altasciences, our full-time equivalent (FTE) solutions give you access to capabilities and expertise tailored to your requirements. Our experts treat your priorities with the same level of commitment to timelines and deliverables as you do.

Find out how our FTE program can benefit you

This site uses cookies to store information on your computer and improve your browsing experience. By remaining on this site, you consent to the placement of these cookies. Read our Cookie Policy to learn more.

THERAPEUTIC AREAS

Our deep expertise and capabilities in a broad range of therapeutic areas encompasses preclinical and early clinical studies for both small molecules and biologics. We can manage your entire program, as well as provide comprehensive support research services and bioanalytical expertise.

Please see Therapeutic Areas for a fuller discussion of our capabilities and expertise.

Learn More

Working as a flexible, attentive extension of your team, we offer all you need to move your molecule forward.

Send Us A Message

STAY CONNECTED

2019 © Altasciences. All Rights Reserved.

Cookie Policy | Privacy Policy